Boerhout C K M, Feenstra R G T, Somsen G A, Appelman Y, Ong P, Beijk M A M, Hofstra L, van de Hoef T P, Piek J J
Department of Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, Amsterdam, The Netherlands.
Cardiology Centres of the Netherlands, Amsterdam, The Netherlands.
Neth Heart J. 2021 Nov;29(11):551-556. doi: 10.1007/s12471-021-01639-7. Epub 2021 Oct 21.
Patients with new-onset stable angina constitute a substantial part of the population seen by cardiologists. Currently, the diagnostic workup of these patients depends on the pre-test probability of having obstructive coronary artery disease. It consists of either functional testing for myocardial ischaemia or anatomical testing by using coronary computed tomographic angiography (CCTA) or invasive coronary angiography. In case the pre-test probability is > 5%, the current guidelines for the management of chronic coronary syndromes do not state a clear preference for one of the noninvasive techniques. However, based on the recently published cost-effectiveness analysis of the PROMISE trial and considering the diagnostic yield in patients with angina and nonobstructive coronary artery disease, we argue a more prominent role for CCTA as a gatekeeper for patients with new-onset stable angina.
新发稳定性心绞痛患者占心脏病专家诊治人群的很大一部分。目前,这些患者的诊断检查取决于患阻塞性冠状动脉疾病的预检概率。其检查方式包括心肌缺血功能测试,或使用冠状动脉计算机断层扫描血管造影(CCTA)或有创冠状动脉造影进行解剖学检查。如果预检概率>5%,目前慢性冠状动脉综合征管理指南并未明确表明对其中一种非侵入性技术的偏好。然而,基于最近发表的PROMISE试验成本效益分析,并考虑到心绞痛和非阻塞性冠状动脉疾病患者的诊断率,我们认为CCTA作为新发稳定性心绞痛患者的守门人应发挥更突出的作用。